Synopsis of recent research by authors named "Cathy Hardalo"
- Cathy Hardalo's research primarily focuses on vaccine safety and immunogenicity, notably investigating the V590 rVSV-SARS-CoV-2 vaccine as a potential solution to combat COVID-19 through a comprehensive phase 1 clinical trial.
- In addition to vaccine studies, Hardalo has assessed the safety and tolerability of tedizolid phosphate, contributing to the understanding of its efficacy in treating bacterial skin infections through pooled data from multiple clinical trials.
- The author also conducted research on antifungal prophylaxis in neutropenic patients, comparing the effectiveness and safety of posaconazole against traditional treatments, enhancing knowledge regarding optimal therapeutic strategies for vulnerable patient populations.